Strathprints Home | Open Access | Browse | Search | User area | Copyright | Help | Library Home | SUPrimo

The use of targeted radionuclide therapy for the treatment of malignant melanoma in vivo

Joyce, C. and Boyd, M. and Sorensen, A. and Tesson, M. and Babich, J. W. and Mairs, R. J. (2012) The use of targeted radionuclide therapy for the treatment of malignant melanoma in vivo. [Proceedings Paper]

Full text not available in this repository. (Request a copy from the Strathclyde author)

Abstract

This study investigates the potential of the noradrenaline analogue [131I]MIBG (metaiodobenzylguanidine) and the novel melanin binding benzamide [131I] Solazed for melanoma therapy in vivo and in vitro.

Item type: Proceedings Paper
ID code: 40173
Keywords: targeted radionuclide therapy, treatment, malignant melanoma , in vivo, in vitro, noradrenaline analogue , metaiodobenzylguanidine, Pharmacy and materia medica
Subjects: Medicine > Pharmacy and materia medica
Department: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
Technology and Innovation Centre > Advanced Science and Technology
Technology and Innovation Centre > Bionanotechnology
Related URLs:
    Depositing user: Pure Administrator
    Date Deposited: 22 Jun 2012 12:06
    Last modified: 12 Jun 2013 14:34
    URI: http://strathprints.strath.ac.uk/id/eprint/40173

    Actions (login required)

    View Item